Stock Earnings

Question 1

NuGen Medical Devices Inc의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, NuGen Medical Devices Inc의 총 자산은 $13이며, 순loss입니다.

Question 2

NGMDF의 주요 재무 비율은 무엇인가요?

Accepted Answer

NuGen Medical Devices Inc의 유동비율은 0.68이고, 순이익률은 -500, 주당 매출은 $0입니다.

Question 3

NuGen Medical Devices Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

NuGen Medical Devices Inc largest revenue segment is Needless Injector Devices, at a revenue of 331,403 in the most earnings release.For geography, Europe is the primary market for NuGen Medical Devices Inc, at a revenue of 164,433.

Question 4

NuGen Medical Devices Inc은 수익성이 있나요?

Accepted Answer

no, 최신 재무제표에 따르면 NuGen Medical Devices Inc의 순loss은 $-5입니다.

Question 5

NuGen Medical Devices Inc에 부채가 있나요?

Accepted Answer

yes, NuGen Medical Devices Inc의 부채는 19입니다.

Question 6

NuGen Medical Devices Inc의 발행 주식은 몇 주인가요?

Accepted Answer

NuGen Medical Devices Inc의 총 발행 주식은 226주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	1	1	0	0	0
Revenue Growth (YoY)	--	--	--	--	--
Cost of Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Selling, General & Admin	4	5	7	4	5
Research & Development	--	--	--	--	--
Operating Expenses	5	5	8	4	7
Other Non Operating Income (Expenses)	0	0	0	0	0
Pretax Income	-3	-5	-9	-5	-7
Income Tax Expense	0	0	0	0	0
Net Income	-3	-5	-9	-5	-7
Net Income Growth	-56.99%	-44%	80%	-28.99%	--
Shares Outstanding (Diluted)	227.03	214.42	167.66	90.1	68.67
Shares Change (YoY)	5%	28%	86%	31%	--
EPS (Diluted)	-0.01	-0.02	-0.05	-0.06	-0.1
EPS Growth	-62%	-56%	-10%	-40%	--
Free Cash Flow	-5	-4	-6	-2	-4
Free Cash Flow Per Share	-0.02	-0.01	-0.03	-0.02	-0.05
Gross Margin	0%	0%	0%	0%	0%
Operating Margin	-400%	-500%	0%	0%	0%
Profit Margin	-300%	-500%	0%	0%	0%
Free Cash Flow Margin	-500%	-400%	0%	0%	0%
EBITDA	-4	-5	-8	-4	-7
EBITDA Margin	-400%	-500%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0
EBIT	-4	-5	-8	-4	-7
EBIT Margin	-400%	-500%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%

NuGen Medical Devices Inc (NGMDF) Price

NGMDF Stock Price Chart

NGMDF Income

Follow-Up Questions